³í¹®) The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in elderly(≥65) patients with acute myocardial infarction without hypertension °í·Á´ëÇб³ ±¸·Îº´¿ø ½ÉÇ÷°ü¼¾ÅÍ ³ª½Â¿î ±³¼ö(»çÁø ñ§), °í·Á´ë ½ÉÀåÇ÷°ü¿¬±¸¼Ò ÃÖº´°É ±³¼ö(ñé), °í´ëÀÇ´ë ¾È¿ìÁø ±º(éÓ) ¿¬±¸ÆÀ